| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
Deluccia Robert J is a Director, 10% Owner at Acurx Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 49,261 | $1.02 | $49,999.91 | +5.1% | -69.9% | -86.6% | |
| Jul 27, 2022 | ACXP Acurx Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 19,737 | $3.80 | $75,000.60 | +1.9% | -13.2% | -52.4% | |
| Nov 19, 2021 | ACXP Acurx Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 5,034 | $4.90 | $24,671.63 | +0.5% | -17.5% | -35.0% |